VAXIRNA

Serial Number 85032584
606

Registration Progress

Application Filed
May 7, 2010
Under Examination
Sep 27, 2011
Approved for Publication
Jul 13, 2011
Published for Opposition
Aug 2, 2011
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: VAXIRNA
Previous Owner: Alnylam Pharmaceuticals, Inc.
Classes: 005, 042

Trademark Image

VAXIRNA

Basic Information

Serial Number
85032584
Filing Date
May 7, 2010
Published for Opposition
August 2, 2011
Abandonment Date
November 3, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 3, 2014
Classes
005 042

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street, 3rd Floor
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Ann Lamport Hammitte

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

42 events
Date Code Type Description Documents
Nov 3, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 3, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 26, 2014 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Mar 25, 2014 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 13, 2014 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Sep 24, 2013 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 10, 2013 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 10, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 26, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Feb 25, 2013 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 21, 2013 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 21, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Sep 28, 2012 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 26, 2012 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 26, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 13, 2012 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Mar 12, 2012 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 15, 2012 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 12, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 15, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 27, 2011 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 2, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 13, 2011 NPUB O NOTICE OF PUBLICATION Loading...
Jun 24, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 22, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 18, 2011 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Jun 18, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 6, 2011 MAIL I PAPER RECEIVED Loading...
Apr 13, 2011 CNRT O NON-FINAL ACTION MAILED Loading...
Apr 13, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 15, 2011 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Mar 15, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 8, 2011 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2011 MAIL I PAPER RECEIVED Loading...
Aug 24, 2010 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 24, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 19, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
May 13, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 11, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
a full line of pharmaceutical preparations, biological preparations, and vaccines for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
scientific research, scientific research in the fields of pharmaceuticals, vaccines and medicine; pharmaceutical, biological and vaccine research and development services; consulting services in the field of researching and development of pharmaceutical preparations, vaccines and biologics
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042